Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
12/2005
12/14/2005EP1198457B1 Quaternized azafluorenones and their use in agents for dying fibers containing keratin
12/14/2005CN1231484C Benzo [b] pyran-[3,2-h] acridinyl-7-one compounds, their prepn and medicine composition containing them
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/13/2005US6974827 For use as pesticides and herbicides
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005089294A3 Synthesis of indenoisoquinoliniums and methods of use
12/08/2005WO2005082860A8 Tetracyclines and their use as calpain inhibitors
12/08/2005WO2005062894A3 Co-administration of dopamine-receptor binding compounds
12/08/2005WO2005058298B1 Fk228 analogs and their use as hdac-inhibitors
12/08/2005WO2005009951A3 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1704405A Method for analyzing and separating preparation of Huperzine A and Huperzine B
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267142 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
12/01/2005US20050267139 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267138 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005CA2767912A1 Synthesis of tetracyclines and analogues thereof
11/2005
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005US20050261329 administering morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide for prevention or treatment of viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers
11/24/2005US20050261288 Tetracyclic lactam derivatives and uses thereof
11/24/2005US20050261266 Apomorphine derivatives; radioimaging agents upon incorporation of radionuclides; neuronal function diagnosis
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/22/2005CA2257094C Sterically hindered 4-amino-piperidine with a low dimer content, its production and use
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107763A2 Radiopharmaceutical and methods of synthesis and use thereof
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005US20050256089 for use as pesticides, herbicides; condensation
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050253983 Providing solutions containing selected concentrations of soluble orienting compounds in an isotropic phase or in a lyotropic liquid-crystalline phase, introducing solutions into template having at least one dimension that is micro- or nanoscaled, removing sufficient solvent to form anisotropic solid
11/17/2005CA2564005A1 Radiopharmaceutical and methods of synthesis and use thereof
11/16/2005EP1476429B1 Novel pyridine- and quinoline-derivatives
11/10/2005WO2005105753A2 Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
11/10/2005WO2005105752A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005WO2005058298A3 Fk228 analogs and their use as hdac-inhibitors
11/10/2005US20050250807 Neurotrophin antagonist compositions
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/10/2005CA2565018A1 Fused quinoline derivative and use thereof
11/10/2005CA2562400A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
11/10/2005CA2555718A1 Naphthalimide derivatives for the treatment of cancer
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1694882A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
11/03/2005WO2005103009A1 Alkaloid compounds and their use as anti-malarial drugs
11/03/2005WO2005103008A1 Alkaloid compounds and their use as anti-malarial drugs
11/03/2005WO2005102250A1 Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and a polymer containing said monomer compound and the use thereof
11/03/2005WO2005082079A3 Tetracyclic lactam derivatives and uses thereof
11/03/2005US20050245744 Method for the preparation of highly pure 1-androstene derivatives
11/03/2005US20050245741 Novel tricyclic spiropiperidines or spiropyrrolidines
11/03/2005US20050245570 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005CA2581488A1 Alkaloid compounds and their use as anti-malarial drugs
11/01/2005US6960666 administering an azabicyclo or azatricyclo compound to treat inflammatory diseases such as asthma
10/2005
10/27/2005WO2005099707A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators
10/27/2005WO2005099702A2 R(-)-11-hydroxyaporphine derivatives and uses thereof
10/27/2005US20050239818 acetic acid (3RS,4aRS,10bRS)-6-(3,4-bis-cyclopropylmethoxyphenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-3-yl ester, phosphodiesterase inhibitor; antiinflammatory, bronchodilator agent; bronchitis, allergic bronchitis, asthma, COPD, psoriasis, eczema, osteoarthritis, rheumatoid arthritis
10/27/2005US20050239817 Acetic acid 6-(3,4-bis-cyclopropylmethoxy-phenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-2-yl ester; low toxicity; high bioavailability; large therapeutic breadth; side effects reduction; industrial scale; antiinflammatory agent, asthma, COPD, allergic rhinitis or Crohn's disease
10/27/2005US20050239816 Amonafide salts
10/27/2005US20050239812 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
10/27/2005US20050239810 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
10/27/2005US20050239782 Arylindenopyridines and related therapeutic and prophylactic methods
10/27/2005US20050239107 Trapped photochromes and thermochromes and uses for chromogenic detection, including detection of airborne contaminants
10/27/2005CA2562465A1 R(-)-11-hydroxyaporphine derivatives and uses thereof
10/27/2005CA2562369A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005CA2562132A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators
10/26/2005EP1589004A1 Alkaloid compounds and their use as anti-malarial drugs
10/26/2005EP1587794A1 Process for the preparation of aryl fused polycyclic lactams
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/25/2005US6958347 Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
10/25/2005US6958328 5H-indeno(1,2-b)pyridine-3-carboxylic acid,4-phenyl-2-amino-5-oxo-, ethyl ester; adenosine receptor antagonists, phosphodiesterase inhibitors; neurodegenerative disorders, AIDS; antiinflammatory agent
10/20/2005WO2005097776A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
10/20/2005WO2005097753A1 Method for producing perylene tetracarboxylic diimide derivatives
10/20/2005WO2005097713A1 Fluoridation method
10/20/2005WO2005097128A1 1,4-bis-n-oxide azaanthracenediones and the use thereof
10/20/2005US20050234096 Tetrahydroisoquinoline derivatives
10/20/2005US20050233465 Compositions of matter useful as pH indicators and related methods
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005CA2557010A1 Compounds and methods for treating dyslipidemia
10/19/2005EP1585516A2 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
10/19/2005CN1684965A Novel 1, 4-diazabicycloalkane derivatives, their preparation and use
10/19/2005CN1683340A 2-nitro-gen-dicyclic [2, 2, 1] hepta-5-ene-3-carboxylic derivative and its use preparing neuro regulator
10/18/2005US6956035 Isoquinoline derivatives and methods of use thereof
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/13/2005WO2005084104A3 Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050228007 Treating cancer with tetracyclic benzamide derivatives; synthesis
10/13/2005US20050227307 2-hydroxyethidium, methods of preparation and uses thereof
10/12/2005EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 110